Saba Capital Amends Filing for Nuveen Real Asset Income & Growth Fund
Ticker: JRI · Form: SC 13D/A · Filed: Aug 21, 2024 · CIK: 1539337
| Field | Detail |
|---|---|
| Company | Nuveen Real Asset Income & Growth Fund (JRI) |
| Form Type | SC 13D/A |
| Filed Date | Aug 21, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 5 min |
| Key Dollar Amounts | $0.01, $15,476,085 |
| Sentiment | neutral |
Sentiment: neutral
Topics: sec-filing, schedule-13d, amendment
TL;DR
Saba Capital updated its filing for Nuveen Real Asset Income & Growth Fund - no major changes disclosed yet.
AI Summary
Saba Capital Management, L.P. filed an amendment (Amendment No. 7) to its Schedule 13D on August 20, 2024, regarding its holdings in Nuveen Real Asset Income & Growth Fund. The filing indicates a change in reporting, but does not specify new share acquisitions or sales. Saba Capital Management, L.P. is the filer, with Boaz R. Weinstein also listed as a group member.
Why It Matters
This amendment signals ongoing activity or changes in reporting by a significant shareholder, potentially impacting the market perception and trading of Nuveen Real Asset Income & Growth Fund's shares.
Risk Assessment
Risk Level: medium — Amendments to Schedule 13D filings can indicate shifts in a major shareholder's strategy or intentions, which could lead to increased volatility.
Key Players & Entities
- Saba Capital Management, L.P. (company) — Filer of the Schedule 13D/A
- Nuveen Real Asset Income & Growth Fund (company) — Subject company of the filing
- Boaz R. Weinstein (person) — Group member associated with the filing
- Michael D'Angelo (person) — Authorized contact for Saba Capital Management, L.P.
FAQ
What specific changes are detailed in Amendment No. 7 to the Schedule 13D?
The filing is an amendment (Amendment No. 7) to the Schedule 13D, but the provided text does not detail specific changes in share ownership or strategy.
Who is the primary filer of this Schedule 13D/A?
Saba Capital Management, L.P. is the primary filer of this Schedule 13D/A.
What is the CUSIP number for Nuveen Real Asset Income & Growth Fund's common shares?
The CUSIP number for Nuveen Real Asset Income & Growth Fund's common shares is 67074Y105.
When was the event requiring this filing amendment?
The date of the event which requires filing of this statement is August 20, 2024.
What is the business address of Saba Capital Management, L.P.?
The business address of Saba Capital Management, L.P. is 405 Lexington Avenue, 58th Floor, New York, NY 10174.
Filing Stats: 1,361 words · 5 min read · ~5 pages · Grade level 10.7 · Accepted 2024-08-21 11:37:41
Key Financial Figures
- $0.01 — Fund (Name of Issuer) Common Shares, $0.01 par value (Title of Class of Securiti
- $15,476,085 — ported herein. A total of approximately $15,476,085 was paid to acquire the Common Shares r
Filing Documents
- formsc13da.htm (SC 13D/A) — 58KB
- 0001062993-24-015502.txt ( ) — 60KB
SIGNATURES
SIGNATURES After reasonable inquiry and to the best of his or its knowledge and belief, each of the undersigned certifies that the information set forth in this statement is true, complete and correct. Date: August 21, 2024 SABA CAPITAL MANAGEMENT, L.P. By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Chief Compliance Officer SABA CAPITAL MANAGEMENT GP, LLC By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Authorized Signatory BOAZ R. WEINSTEIN By: /s/ Michael D'Angelo Name: Michael D'Angelo Title: Attorney-in-fact* * Pursuant to a power of attorney dated as of November 16, 2015, which is incorporated herein by reference to Exhibit 2 to the Schedule 13G filed by the Reporting Persons on December 28, 2015, accession number: 0001062993-15-006823 CUSIP No. 67074Y105 SCHEDULE 13D/A Page 7 of 7 Pages Schedule A This Schedule sets forth information with respect to each purchase and sale of Common Shares which were effectuated by Saba Capital since the filing of the Schedule 13D/A on 8/2/24. All transactions were effectuated in the open market through a broker. Trade Date Buy/Sell Shares Price 8/2/2024 Sell 22,409 12.57 8/6/2024 Sell 48,501 12.35 8/7/2024 Sell 10,019 12.55 8/8/2024 Sell 22,362 12.48 8/9/2024 Sell 15,593 12.56 8/12/2024 Sell 19,070 12.58 8/13/2024 Sell 32,782 12.64 8/14/2024 Sell 52,217 12.70 8/15/2024 Sell 23,010 12.69 8/16/2024 Sell 4,345 12.72 8/19/2024 Sell 1,214 12.82 8/20/2024 Sell 28,379 12.78